Optimal Strategies to Identify Aberrant Intra-Epithelial Lymphocytes in Refractory Coeliac Disease
- 27 July 2014
- journal article
- research article
- Published by Springer Nature in Journal of Clinical Immunology
- Vol. 34 (7) , 828-835
Abstract
Different strategies have been developed to identify those refractory celiac disease (RCD) patients who are at risk to develop an enteropathy associated T-cell lymphoma (EATL). Flow cytometric analysis of intra-epithelial lymphocytes (IEL) with an aberrant phenotype is considered the golden standard but is not widely available. Immunohistochemistry (IHC) and T-cell receptor (TCR) rearrangement studies are commonly available but may lack sensitivity and specificity. Here, we compared the three different methods in the workup of patients suspected for RCD.Keywords
This publication has 26 references indexed in Scilit:
- Anti-TCR gamma antibody in celiac disease: the value of count on formalin-fixed paraffin-embedded biopsies.Virchows Archiv, 2013
- Update on the Diagnosis and Management of Refractory Coeliac DiseaseGastroenterology Research and Practice, 2013
- Origin and immunophenotype of aberrant IEL in RCDII patientsMolecular Immunology, 2012
- How I treat enteropathy-associated T-cell lymphomaBlood, 2012
- Noncoeliac enteropathy: the differential diagnosis of villous atrophy in contemporary clinical practiceAlimentary Pharmacology & Therapeutics, 2011
- Evaluation of Cladribine treatment in refractory celiac disease type IIWorld Journal of Gastroenterology, 2011
- Classification and management of refractory coeliac diseaseGut, 2010
- Clinical Staging and Survival in Refractory Celiac Disease: A Single Center ExperienceGastroenterology, 2009
- Survival in refractory coeliac disease and enteropathy-associated T-cell lymphoma: retrospective evaluation of single-centre experienceGut, 2007
- Refractory sprue, coeliac disease, and enteropathy-associated T-cell lymphomaThe Lancet, 2000